Analysis of destination markets, infrastructure, and attractions, as well as risks and opportunities in the South America region. This report explores the types of travelers that visit the region as well as a SWOT analysis.
Scope
- This report is part of the analyst's Destination Market Insights Series. These reports provide an in-depth analysis of a tourist destination and its key source markets, as well as an assessment of the trends and issues in the covered destination market, in this case the the South America region.
Reasons to Buy
- Obtain a clear and detailed insight into new developments in a highly popular tourist destination.
- Use data and analysis to explore future trends related to international arrivals, airlines, niche tourism, and hotel developments.
- Gain a strong understanding of the opportunities in the market, as well as the risks, to support better business decisions.
Table of Contents
1 Introduction
1.1 What Is This Report About?
1.2 Peripheral Vascular Devices Market Segmentation
1.3 Definitions of Markets Covered in the Report
1.2 Peripheral Vascular Devices Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Peripheral Vascular Devices Market, North America
2.1 Peripheral Vascular Devices Market, North America, Revenue ($m), 2024-2036
2.2 Peripheral Vascular Devices Market, North America, Revenue ($m), 2024-2036
2.3 Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
2.4 Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
2.5 Peripheral Vascular Devices Market, North America, Company Share by Revenue ($m), 2025
2.2 Peripheral Vascular Devices Market, North America, Revenue ($m), 2024-2036
2.3 Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
2.4 Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
2.5 Peripheral Vascular Devices Market, North America, Company Share by Revenue ($m), 2025
3 Peripheral Vascular Devices Market, Canada
3.1 Peripheral Vascular Devices Market, Canada, Revenue ($m), 2024-2036
3.1.1 Arteriotomy Closure Devices Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.2 Carotid and Renal Artery Stents Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.3 Peripheral Accessories Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.4 Peripheral Embolic Protection Devices Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.5 Peripheral Vascular Stents Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.6 PTA Balloon Catheters Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.7 Renal Denervation Catheters Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.8 Superficial Vein Devices Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.9 Vascular Embolization Plugs and Coils Market, Canada, Revenue ($m), by Segment, 2024-2036
3.2 Peripheral Vascular Devices Market, Canada, Volume (Units), 2024-2036
3.2.1 Arteriotomy Closure Devices Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.2 Carotid and Renal Artery Stents Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.3 Peripheral Accessories Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.4 Peripheral Embolic Protection Devices Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.5 Peripheral Vascular Stents Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.6 PTA Balloon Catheters Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.7 Renal Denervation Catheters Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.8 Superficial Vein Devices Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.9 Vascular Embolization Plugs and Coils Market, Canada, Volume (Units), by Segment, 2024-2036
3.3 Peripheral Vascular Devices Market, Canada, Average Price ($), 2024-2036
3.4 Peripheral Vascular Devices Market, Canada, Company Share by Revenue ($m), 2025
3.1.1 Arteriotomy Closure Devices Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.2 Carotid and Renal Artery Stents Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.3 Peripheral Accessories Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.4 Peripheral Embolic Protection Devices Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.5 Peripheral Vascular Stents Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.6 PTA Balloon Catheters Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.7 Renal Denervation Catheters Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.8 Superficial Vein Devices Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.9 Vascular Embolization Plugs and Coils Market, Canada, Revenue ($m), by Segment, 2024-2036
3.2 Peripheral Vascular Devices Market, Canada, Volume (Units), 2024-2036
3.2.1 Arteriotomy Closure Devices Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.2 Carotid and Renal Artery Stents Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.3 Peripheral Accessories Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.4 Peripheral Embolic Protection Devices Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.5 Peripheral Vascular Stents Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.6 PTA Balloon Catheters Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.7 Renal Denervation Catheters Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.8 Superficial Vein Devices Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.9 Vascular Embolization Plugs and Coils Market, Canada, Volume (Units), by Segment, 2024-2036
3.3 Peripheral Vascular Devices Market, Canada, Average Price ($), 2024-2036
3.4 Peripheral Vascular Devices Market, Canada, Company Share by Revenue ($m), 2025
4 Peripheral Vascular Devices Market, Mexico
4.1 Peripheral Vascular Devices Market, Mexico, Revenue ($m), 2024-2036
4.1.1 Arteriotomy Closure Devices Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.2 Peripheral Embolic Protection Devices Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.3 Carotid and Renal Artery Stents Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.4 Peripheral Accessories Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.5 Peripheral Vascular Stents Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.6 PTA Balloon Catheters Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.7 Renal Denervation Catheters Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.8 Superficial Vein Devices Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.9 Vascular Embolization Plugs and Coils Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.2 Peripheral Vascular Devices Market, Mexico, Volume (Units), 2024-2036
4.2.1 Arteriotomy Closure Devices Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.2 Carotid and Renal Artery Stents Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.3 Peripheral Accessories Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.4 Peripheral Embolic Protection Devices Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.5 Peripheral Vascular Stents Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.6 PTA Balloon Catheters Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.7 Renal Denervation Catheters Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.8 Superficial Vein Devices Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.9 Vascular Embolization Plugs and Coils Market, Mexico, Volume (Units), by Segment, 2024-2036
4.3 Peripheral Vascular Devices Market, Mexico, Average Price ($), 2024-2036
4.4 Peripheral Vascular Devices Market, Mexico, Company Share by Revenue ($m), 2025
4.1.1 Arteriotomy Closure Devices Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.2 Peripheral Embolic Protection Devices Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.3 Carotid and Renal Artery Stents Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.4 Peripheral Accessories Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.5 Peripheral Vascular Stents Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.6 PTA Balloon Catheters Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.7 Renal Denervation Catheters Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.8 Superficial Vein Devices Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.9 Vascular Embolization Plugs and Coils Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.2 Peripheral Vascular Devices Market, Mexico, Volume (Units), 2024-2036
4.2.1 Arteriotomy Closure Devices Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.2 Carotid and Renal Artery Stents Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.3 Peripheral Accessories Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.4 Peripheral Embolic Protection Devices Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.5 Peripheral Vascular Stents Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.6 PTA Balloon Catheters Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.7 Renal Denervation Catheters Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.8 Superficial Vein Devices Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.9 Vascular Embolization Plugs and Coils Market, Mexico, Volume (Units), by Segment, 2024-2036
4.3 Peripheral Vascular Devices Market, Mexico, Average Price ($), 2024-2036
4.4 Peripheral Vascular Devices Market, Mexico, Company Share by Revenue ($m), 2025
5 Peripheral Vascular Devices Market, United States
5.1 Peripheral Vascular Devices Market, United States, Revenue ($m), 2024-2036
5.1.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.2 Carotid and Renal Artery Stents Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.3 Peripheral Accessories Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.4 Peripheral Embolic Protection Devices Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.5 Peripheral Vascular Stents Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.6 PTA Balloon Catheters Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.7 Renal Denervation Catheters Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.8 Superficial Vein Devices Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.9 Vascular Embolization Plugs and Coils Market, United States, Revenue ($m), by Segment, 2024-2036
5.2 Peripheral Vascular Devices Market, United States, Volume (Units), 2024-2036
5.2.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2024-2036
5.2.2 Carotid and Renal Artery Stents Market, United States, Volume (Units), by Segment, 2024-2036
5.2.3 Peripheral Accessories Market, United States, Volume (Units), by Segment, 2024-2036
5.2.4 Peripheral Embolic Protection Devices Market, United States, Volume (Units), by Segment, 2024-2036
5.2.5 Peripheral Vascular Stents Market, United States, Volume (Units), by Segment, 2024-2036
5.2.6 PTA Balloon Catheters Market, United States, Volume (Units), by Segment, 2024-2036
5.2.7 Renal Denervation Catheters Market, United States, Volume (Units), by Segment, 2024-2036
5.2.8 Superficial Vein Devices Market, United States, Volume (Units), by Segment, 2024-2036
5.2.9 Vascular Embolization Plugs and Coils Market, United States, Volume (Units), by Segment, 2024-2036
5.3 Peripheral Vascular Devices Market, United States, Average Price ($), 2024-2036
5.4 Peripheral Vascular Devices Market, United States, Company Share by Revenue ($m), 2025
5.1.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.2 Carotid and Renal Artery Stents Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.3 Peripheral Accessories Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.4 Peripheral Embolic Protection Devices Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.5 Peripheral Vascular Stents Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.6 PTA Balloon Catheters Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.7 Renal Denervation Catheters Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.8 Superficial Vein Devices Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.9 Vascular Embolization Plugs and Coils Market, United States, Revenue ($m), by Segment, 2024-2036
5.2 Peripheral Vascular Devices Market, United States, Volume (Units), 2024-2036
5.2.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2024-2036
5.2.2 Carotid and Renal Artery Stents Market, United States, Volume (Units), by Segment, 2024-2036
5.2.3 Peripheral Accessories Market, United States, Volume (Units), by Segment, 2024-2036
5.2.4 Peripheral Embolic Protection Devices Market, United States, Volume (Units), by Segment, 2024-2036
5.2.5 Peripheral Vascular Stents Market, United States, Volume (Units), by Segment, 2024-2036
5.2.6 PTA Balloon Catheters Market, United States, Volume (Units), by Segment, 2024-2036
5.2.7 Renal Denervation Catheters Market, United States, Volume (Units), by Segment, 2024-2036
5.2.8 Superficial Vein Devices Market, United States, Volume (Units), by Segment, 2024-2036
5.2.9 Vascular Embolization Plugs and Coils Market, United States, Volume (Units), by Segment, 2024-2036
5.3 Peripheral Vascular Devices Market, United States, Average Price ($), 2024-2036
5.4 Peripheral Vascular Devices Market, United States, Company Share by Revenue ($m), 2025
6 Peripheral Vascular Devices Market Pipeline Products
6.1 Peripheral Vascular Devices Market Pipeline Products
6.2 Peripheral Vascular Devices - Pipeline Products by Stage of Development
6.3 Peripheral Vascular Devices - Pipeline Products by Segment
6.4 Peripheral Vascular Devices - Pipeline Products by Territory
6.5 Peripheral Vascular Devices - Pipeline Products by Regulatory Path
6.6 Peripheral Vascular Devices - Pipeline Products by Estimated Approval Date
6.2 Peripheral Vascular Devices - Pipeline Products by Stage of Development
6.3 Peripheral Vascular Devices - Pipeline Products by Segment
6.4 Peripheral Vascular Devices - Pipeline Products by Territory
6.5 Peripheral Vascular Devices - Pipeline Products by Regulatory Path
6.6 Peripheral Vascular Devices - Pipeline Products by Estimated Approval Date
7 Overview of Key Companies in North America Peripheral Vascular Devices Market
7.1 Medtronic Plc
7.1.1 Company Overview
7.2 W. L. Gore & Associates Inc
7.2.1 Company Overview
7.3 Abbott Laboratories
7.3.1 Company Overview
7.4 Boston Scientific Corp
7.4.1 Company Overview
7.5 Terumo Corp
7.5.1 Company Overview
7.6 Becton Dickinson and Co
7.6.1 Company Overview
7.7 Penumbra Inc
7.7.1 Company Overview
7.8 Shockwave Medical Inc
7.8.1 Company Overview
7.9 Cordis Corp
7.9.1 Company Overview
7.10 Silk Road Medical Inc
7.10.1 Company Overview
7.1.1 Company Overview
7.2 W. L. Gore & Associates Inc
7.2.1 Company Overview
7.3 Abbott Laboratories
7.3.1 Company Overview
7.4 Boston Scientific Corp
7.4.1 Company Overview
7.5 Terumo Corp
7.5.1 Company Overview
7.6 Becton Dickinson and Co
7.6.1 Company Overview
7.7 Penumbra Inc
7.7.1 Company Overview
7.8 Shockwave Medical Inc
7.8.1 Company Overview
7.9 Cordis Corp
7.9.1 Company Overview
7.10 Silk Road Medical Inc
7.10.1 Company Overview
8 Recent Developments
8.1 Corporate Communications
8.1.1 Apr 07, 2026: TriSalus Life Sciences Appoints Richard Marshall, M.D., as Chief Medical Officer
8.1.2 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
8.1.3 Nov 25, 2025: SNF Agora Institute at Johns Hopkins Begins Search for Next Director
8.1.4 Nov 21, 2025: Johnson & Johnson Signs National Charter for Mental Health at Work
8.1.5 Nov 21, 2025: Daniel Weiss to Leave Johns Hopkins to Lead Philadelphia Art Museum
8.1.6 Nov 17, 2025: BD Appoints Robert Huffines And Jacqueline Wright To Board Of Directors
8.1.7 Nov 17, 2025: Biomedix Welcomes New VP of Customer Success and Growth
8.1.8 Nov 06, 2025: RenovoRx Appoints Pancreatic Cancer Expert Timothy Donahue, MD, to Scientific Advisory Board
8.1.9 Nov 06, 2025: Applications Open For Catalyst And Discovery Awards
8.1.10 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager
8.1.11 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.1.12 Oct 30, 2025: Edwards Lifesciences CFO Transition Plan Announced
8.1.13 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.1.14 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.1.15 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.1.16 Oct 24, 2025: Payman Khales Becomes Integer President and CEO
8.1.17 Oct 20, 2025: Committee Tasked With Strategic Planning for JHU's Research Core Facilities
8.1.18 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.1.19 Oct 02, 2025: Ontogen Medtech Achieves ISO 13485 Certification Strengthening Contract Manufacturing Capabilities
8.1.20 Oct 01, 2025: Johns Hopkins, Other Large Nonprofits To Double Annual Contribution To Baltimore
8.1.21 Sep 24, 2025: CWSL Alumna Sherry S. Bahrambeygui Elected to UC San Diego Foundation Board
8.1.22 Sep 23, 2025: DJ Babu Joins Peabody Conservatory Hip-Hop Faculty
8.1.23 Sep 08, 2025: UC San Diego Foundation Announces New Trustees
8.1.24 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
8.1.25 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
8.2 Financial Announcements
8.2.1 Apr 02, 2026: Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
8.2.2 Apr 01, 2026: Stryker to Report First-Quarter Fiscal 2026 Results
8.2.3 Mar 30, 2026: RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update
8.2.4 Feb 24, 2026: Merit Medical Reports Fourth Quarter and Full-Year 2025 Results, Provides Fiscal 2026 Guidance
8.2.5 Feb 17, 2026: Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information
8.2.6 Feb 17, 2026: Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information
8.2.7 Feb 03, 2026: Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
8.2.8 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
8.2.9 Nov 14, 2025: Aspira Announces Third Quarter 2025 Financial Results and Provides Business Update
8.2.10 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.2.11 Nov 06, 2025: Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
8.2.12 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.2.13 Oct 27, 2025: RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call
8.2.14 Oct 23, 2025: Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025
8.2.15 Oct 03, 2025: Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
8.2.16 Oct 02, 2025: AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results
8.2.17 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
8.2.18 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
8.2.19 Jul 22, 2025: Semler Scientific Announces Earnings Release Date and Live Video Webinar for Second Quarter 2025 Financial Results
8.2.20 Jul 18, 2025: Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
8.2.21 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
8.2.22 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
8.2.23 Jul 01, 2025: Penumbra Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025
8.3 Government and Public Interest
8.3.1 Mar 20, 2026: NHS provides update on supply chain issues following cyber attack on Stryker
8.3.2 Feb 27, 2026: LeMaitre to Participate at Upcoming Investor Conferences in March
8.3.3 Feb 23, 2026: AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
8.3.4 Feb 09, 2026: Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference
8.3.5 Dec 22, 2025: AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference
8.3.6 Nov 11, 2025: TriSalus Life Sciences to Participate in Upcoming Investor Conferences
8.3.7 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.3.8 Oct 27, 2025: RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call
8.3.9 Oct 27, 2025: AngioDynamics to Participate in the UBS Global Healthcare Conference
8.3.10 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
8.3.11 Aug 20, 2025: Penumbra to Present at Upcoming Investor Conferences
8.3.12 Aug 12, 2025: Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4
8.3.13 Jul 24, 2025: Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference
8.3.14 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
8.3.15 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.4 Legal And Regulatory
8.4.1 Sep 08, 2025: Shareholders Who Lost Money in Semler Scientific Should Contact Wolf Haldenstein
8.5 Other Significant Developments
8.5.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.5.2 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.5.3 Nov 03, 2025: News Updates for Q3 2025
8.5.4 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.5.5 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.5.6 Oct 08, 2025: Linshom Medical Receives 510(K) Clearance For Continuous Predictive Respiratory Monitoring System (CPRMS)
8.5.7 Sep 29, 2025: D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program
8.5.8 Sep 08, 2025: Shape Memory Medical Completes Enrollment in EMBO-PMS Registry
8.6 Product News
8.6.1 Apr 09, 2026: TriSalus Life Sciences to Present New Data at the 2026 Society of Interventional Radiology Annual Scientific Meeting
8.6.2 Mar 03, 2026: Arterial IVUS Tutor App Launched in the US to Support IVUS Training
8.6.3 Feb 23, 2026: BD to Present at Barclays 28th Annual Global Healthcare Conference
8.6.4 Jan 28, 2026: Integer to Highlight Integrated R&D Solutions and Expanded Coating Capabilities at MD&M West 2026
8.6.5 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
8.6.6 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared
8.6.7 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States
8.6.8 Nov 07, 2025: Gore Announces Positive Clinical Trial Results of the Investigational Gore Viabahn Fortegra Venous Stent for Treatment of Patients with Deep Venous Iliocaval Obstruction
8.6.9 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.6.10 Nov 05, 2025: Fluid Control Solutions For MedTech
8.6.11 Nov 04, 2025: AVS Reports Positive Safety and Effectiveness Data from Pulse IVL IDE Study
8.6.12 Nov 04, 2025: Contego Medical Reports 30-Day Outcomes From PERFORMANCE III TCAR-IEP Study
8.6.13 Nov 03, 2025: Johnson & Johnson Confirms Durability of IVL in Complex Below-the-Knee Anatomy
8.6.14 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.6.15 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.6.16 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.6.17 Oct 29, 2025: Hyperion Surgical Announces Completion of First-In-Human Study Using Its Ivy Robotic Vascular Access Platform, Achieving World’s First Robotic-Assisted IV Catheterization
8.6.18 Oct 09, 2025: BD Enrolls First Patient in XTRACT Registry for Rotarex Catheter System
8.6.19 Oct 08, 2025: Medical Manufacturing Solutions for Devices and Equipment
8.6.20 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.6.21 Sep 08, 2025: Shape Memory Medical Completes Enrollment in EMBO-PMS Registry
8.6.22 Sep 08, 2025: Microbot Medical Receives FDA Clearance for LIBERTY Endovascular Robotic System
8.6.23 Aug 20, 2025: RenovoRx CEO Shaun Bagai To Present at H.C. Wainwright’s 27th Annual Global Investment Conference in New York City, September 8-10, 2025
8.6.24 Jul 01, 2025: MedEdge Innovations Unveils New ePTFE Platform and CDMO Services for Medical Implant Applications
8.7 Strategy And Business Planning
8.7.1 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.
8.7.2 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics
8.7.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.7.4 Sep 11, 2025: Penumbra, Inc. Establishes Manufacturing Plant in Costa Rica
8.1.1 Apr 07, 2026: TriSalus Life Sciences Appoints Richard Marshall, M.D., as Chief Medical Officer
8.1.2 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
8.1.3 Nov 25, 2025: SNF Agora Institute at Johns Hopkins Begins Search for Next Director
8.1.4 Nov 21, 2025: Johnson & Johnson Signs National Charter for Mental Health at Work
8.1.5 Nov 21, 2025: Daniel Weiss to Leave Johns Hopkins to Lead Philadelphia Art Museum
8.1.6 Nov 17, 2025: BD Appoints Robert Huffines And Jacqueline Wright To Board Of Directors
8.1.7 Nov 17, 2025: Biomedix Welcomes New VP of Customer Success and Growth
8.1.8 Nov 06, 2025: RenovoRx Appoints Pancreatic Cancer Expert Timothy Donahue, MD, to Scientific Advisory Board
8.1.9 Nov 06, 2025: Applications Open For Catalyst And Discovery Awards
8.1.10 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager
8.1.11 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.1.12 Oct 30, 2025: Edwards Lifesciences CFO Transition Plan Announced
8.1.13 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.1.14 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.1.15 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.1.16 Oct 24, 2025: Payman Khales Becomes Integer President and CEO
8.1.17 Oct 20, 2025: Committee Tasked With Strategic Planning for JHU's Research Core Facilities
8.1.18 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.1.19 Oct 02, 2025: Ontogen Medtech Achieves ISO 13485 Certification Strengthening Contract Manufacturing Capabilities
8.1.20 Oct 01, 2025: Johns Hopkins, Other Large Nonprofits To Double Annual Contribution To Baltimore
8.1.21 Sep 24, 2025: CWSL Alumna Sherry S. Bahrambeygui Elected to UC San Diego Foundation Board
8.1.22 Sep 23, 2025: DJ Babu Joins Peabody Conservatory Hip-Hop Faculty
8.1.23 Sep 08, 2025: UC San Diego Foundation Announces New Trustees
8.1.24 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
8.1.25 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
8.2 Financial Announcements
8.2.1 Apr 02, 2026: Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
8.2.2 Apr 01, 2026: Stryker to Report First-Quarter Fiscal 2026 Results
8.2.3 Mar 30, 2026: RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update
8.2.4 Feb 24, 2026: Merit Medical Reports Fourth Quarter and Full-Year 2025 Results, Provides Fiscal 2026 Guidance
8.2.5 Feb 17, 2026: Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information
8.2.6 Feb 17, 2026: Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information
8.2.7 Feb 03, 2026: Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
8.2.8 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
8.2.9 Nov 14, 2025: Aspira Announces Third Quarter 2025 Financial Results and Provides Business Update
8.2.10 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.2.11 Nov 06, 2025: Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
8.2.12 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.2.13 Oct 27, 2025: RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call
8.2.14 Oct 23, 2025: Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025
8.2.15 Oct 03, 2025: Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
8.2.16 Oct 02, 2025: AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results
8.2.17 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
8.2.18 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
8.2.19 Jul 22, 2025: Semler Scientific Announces Earnings Release Date and Live Video Webinar for Second Quarter 2025 Financial Results
8.2.20 Jul 18, 2025: Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
8.2.21 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
8.2.22 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
8.2.23 Jul 01, 2025: Penumbra Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025
8.3 Government and Public Interest
8.3.1 Mar 20, 2026: NHS provides update on supply chain issues following cyber attack on Stryker
8.3.2 Feb 27, 2026: LeMaitre to Participate at Upcoming Investor Conferences in March
8.3.3 Feb 23, 2026: AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
8.3.4 Feb 09, 2026: Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference
8.3.5 Dec 22, 2025: AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference
8.3.6 Nov 11, 2025: TriSalus Life Sciences to Participate in Upcoming Investor Conferences
8.3.7 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.3.8 Oct 27, 2025: RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call
8.3.9 Oct 27, 2025: AngioDynamics to Participate in the UBS Global Healthcare Conference
8.3.10 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
8.3.11 Aug 20, 2025: Penumbra to Present at Upcoming Investor Conferences
8.3.12 Aug 12, 2025: Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4
8.3.13 Jul 24, 2025: Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference
8.3.14 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
8.3.15 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.4 Legal And Regulatory
8.4.1 Sep 08, 2025: Shareholders Who Lost Money in Semler Scientific Should Contact Wolf Haldenstein
8.5 Other Significant Developments
8.5.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.5.2 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.5.3 Nov 03, 2025: News Updates for Q3 2025
8.5.4 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.5.5 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.5.6 Oct 08, 2025: Linshom Medical Receives 510(K) Clearance For Continuous Predictive Respiratory Monitoring System (CPRMS)
8.5.7 Sep 29, 2025: D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program
8.5.8 Sep 08, 2025: Shape Memory Medical Completes Enrollment in EMBO-PMS Registry
8.6 Product News
8.6.1 Apr 09, 2026: TriSalus Life Sciences to Present New Data at the 2026 Society of Interventional Radiology Annual Scientific Meeting
8.6.2 Mar 03, 2026: Arterial IVUS Tutor App Launched in the US to Support IVUS Training
8.6.3 Feb 23, 2026: BD to Present at Barclays 28th Annual Global Healthcare Conference
8.6.4 Jan 28, 2026: Integer to Highlight Integrated R&D Solutions and Expanded Coating Capabilities at MD&M West 2026
8.6.5 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
8.6.6 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared
8.6.7 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States
8.6.8 Nov 07, 2025: Gore Announces Positive Clinical Trial Results of the Investigational Gore Viabahn Fortegra Venous Stent for Treatment of Patients with Deep Venous Iliocaval Obstruction
8.6.9 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.6.10 Nov 05, 2025: Fluid Control Solutions For MedTech
8.6.11 Nov 04, 2025: AVS Reports Positive Safety and Effectiveness Data from Pulse IVL IDE Study
8.6.12 Nov 04, 2025: Contego Medical Reports 30-Day Outcomes From PERFORMANCE III TCAR-IEP Study
8.6.13 Nov 03, 2025: Johnson & Johnson Confirms Durability of IVL in Complex Below-the-Knee Anatomy
8.6.14 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.6.15 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.6.16 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.6.17 Oct 29, 2025: Hyperion Surgical Announces Completion of First-In-Human Study Using Its Ivy Robotic Vascular Access Platform, Achieving World’s First Robotic-Assisted IV Catheterization
8.6.18 Oct 09, 2025: BD Enrolls First Patient in XTRACT Registry for Rotarex Catheter System
8.6.19 Oct 08, 2025: Medical Manufacturing Solutions for Devices and Equipment
8.6.20 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.6.21 Sep 08, 2025: Shape Memory Medical Completes Enrollment in EMBO-PMS Registry
8.6.22 Sep 08, 2025: Microbot Medical Receives FDA Clearance for LIBERTY Endovascular Robotic System
8.6.23 Aug 20, 2025: RenovoRx CEO Shaun Bagai To Present at H.C. Wainwright’s 27th Annual Global Investment Conference in New York City, September 8-10, 2025
8.6.24 Jul 01, 2025: MedEdge Innovations Unveils New ePTFE Platform and CDMO Services for Medical Implant Applications
8.7 Strategy And Business Planning
8.7.1 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.
8.7.2 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics
8.7.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.7.4 Sep 11, 2025: Penumbra, Inc. Establishes Manufacturing Plant in Costa Rica
9 Appendix
9.1Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 the analyst Consulting
9.3 Contact the Publisher
9.4 Disclaimer
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 the analyst Consulting
9.3 Contact the Publisher
9.4 Disclaimer
List of Tables
Table 1: Peripheral Vascular Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Table 2: Peripheral Vascular Devices Market, North America, Revenue ($m), USD Constant, 2024-2036
Table 3: Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
Table 4: Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
Table 5: Peripheral Vascular Devices Market, North America, Company Share by Revenue ($m), 2025
Table 6: Peripheral Vascular Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 7: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 8: Carotid and Renal Artery Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 9: Peripheral Accessories Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 10: Peripheral Embolic Protection Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 11: Peripheral Vascular Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 12: PTA Balloon Catheters Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 13: Renal Denervation Catheters Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 14: Superficial Vein Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 15: Vascular Embolization Plugs and Coils Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 16: Peripheral Vascular Devices Market, Canada, Volume (Units), 2024-2036
Table 17: Arteriotomy Closure Devices Market, Canada, Volume (Units), 2024-2036
Table 18: Carotid and Renal Artery Stents Market, Canada, Volume (Units), 2024-2036
Table 19: Peripheral Accessories Market, Canada, Volume (Units), 2024-2036
Table 20: Peripheral Embolic Protection Devices Market, Canada, Volume (Units), 2024-2036
Table 21: Peripheral Vascular Stents Market, Canada, Volume (Units), 2024-2036
Table 22: PTA Balloon Catheters Market, Canada, Volume (Units), 2024-2036
Table 23: Renal Denervation Catheters Market, Canada, Volume (Units), 2024-2036
Table 24: Superficial Vein Devices Market, Canada, Volume (Units), 2024-2036
Table 25: Vascular Embolization Plugs and Coils Market, Canada, Volume (Units), 2024-2036
Table 26: Peripheral Vascular Devices Market, Canada, Average Price ($), 2024-2036
Table 27: Peripheral Vascular Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 28: Peripheral Vascular Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 29: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 30: Peripheral Embolic Protection Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 31: Carotid and Renal Artery Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 32: Peripheral Accessories Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 33: Peripheral Vascular Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 34: PTA Balloon Catheters Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 35: Renal Denervation Catheters Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 36: Superficial Vein Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 37: Vascular Embolization Plugs and Coils Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 38: Peripheral Vascular Devices Market, Mexico, Volume (Units), 2024-2036
Table 39: Arteriotomy Closure Devices Market, Mexico, Volume (Units), 2024-2036
Table 40: Carotid and Renal Artery Stents Market, Mexico, Volume (Units), 2024-2036
Table 41: Peripheral Accessories Market, Mexico, Volume (Units), 2024-2036
Table 42: Peripheral Embolic Protection Devices Market, Mexico, Volume (Units), 2024-2036
Table 43: Peripheral Vascular Stents Market, Mexico, Volume (Units), 2024-2036
Table 44: PTA Balloon Catheters Market, Mexico, Volume (Units), 2024-2036
Table 45: Renal Denervation Catheters Market, Mexico, Volume (Units), 2024-2036
Table 46: Superficial Vein Devices Market, Mexico, Volume (Units), 2024-2036
Table 47: Vascular Embolization Plugs and Coils Market, Mexico, Volume (Units), 2024-2036
Table 48: Peripheral Vascular Devices Market, Mexico, Average Price ($), 2024-2036
Table 49: Peripheral Vascular Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025
Table 50: Peripheral Vascular Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 51: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 52: Carotid and Renal Artery Stents Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 53: Peripheral Accessories Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 54: Peripheral Embolic Protection Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 55: Peripheral Vascular Stents Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 56: PTA Balloon Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 57: Renal Denervation Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 58: Superficial Vein Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 59: Vascular Embolization Plugs and Coils Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 60: Peripheral Vascular Devices Market, United States, Volume (Units), 2024-2036
Table 61: Arteriotomy Closure Devices Market, United States, Volume (Units), 2024-2036
Table 62: Carotid and Renal Artery Stents Market, United States, Volume (Units), 2024-2036
Table 63: Peripheral Accessories Market, United States, Volume (Units), 2024-2036
Table 64: Peripheral Embolic Protection Devices Market, United States, Volume (Units), 2024-2036
Table 65: Peripheral Vascular Stents Market, United States, Volume (Units), 2024-2036
Table 66: PTA Balloon Catheters Market, United States, Volume (Units), 2024-2036
Table 67: Renal Denervation Catheters Market, United States, Volume (Units), 2024-2036
Table 68: Superficial Vein Devices Market, United States, Volume (Units), 2024-2036
Table 69: Vascular Embolization Plugs and Coils Market, United States, Volume (Units), 2024-2036
Table 70: Peripheral Vascular Devices Market, United States, Average Price ($), 2024-2036
Table 71: Peripheral Vascular Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 72: Peripheral Vascular Devices Market Pipeline Products
Table 73: Peripheral Vascular Devices - Pipeline Products by Stage of Development
Table 74: Peripheral Vascular Devices Companies - Pipeline Products by Stage of Development
Table 75: Peripheral Vascular Devices - Pipeline Products by Segment
Table 76: Peripheral Vascular Devices - Pipeline Products by Territory
Table 77: Peripheral Vascular Devices - Pipeline Products by Regulatory Path
Table 78: Peripheral Vascular Devices - Pipeline Products by Estimated Approval Date
Table 79: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
Table 2: Peripheral Vascular Devices Market, North America, Revenue ($m), USD Constant, 2024-2036
Table 3: Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
Table 4: Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
Table 5: Peripheral Vascular Devices Market, North America, Company Share by Revenue ($m), 2025
Table 6: Peripheral Vascular Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 7: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 8: Carotid and Renal Artery Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 9: Peripheral Accessories Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 10: Peripheral Embolic Protection Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 11: Peripheral Vascular Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 12: PTA Balloon Catheters Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 13: Renal Denervation Catheters Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 14: Superficial Vein Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 15: Vascular Embolization Plugs and Coils Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 16: Peripheral Vascular Devices Market, Canada, Volume (Units), 2024-2036
Table 17: Arteriotomy Closure Devices Market, Canada, Volume (Units), 2024-2036
Table 18: Carotid and Renal Artery Stents Market, Canada, Volume (Units), 2024-2036
Table 19: Peripheral Accessories Market, Canada, Volume (Units), 2024-2036
Table 20: Peripheral Embolic Protection Devices Market, Canada, Volume (Units), 2024-2036
Table 21: Peripheral Vascular Stents Market, Canada, Volume (Units), 2024-2036
Table 22: PTA Balloon Catheters Market, Canada, Volume (Units), 2024-2036
Table 23: Renal Denervation Catheters Market, Canada, Volume (Units), 2024-2036
Table 24: Superficial Vein Devices Market, Canada, Volume (Units), 2024-2036
Table 25: Vascular Embolization Plugs and Coils Market, Canada, Volume (Units), 2024-2036
Table 26: Peripheral Vascular Devices Market, Canada, Average Price ($), 2024-2036
Table 27: Peripheral Vascular Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 28: Peripheral Vascular Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 29: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 30: Peripheral Embolic Protection Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 31: Carotid and Renal Artery Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 32: Peripheral Accessories Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 33: Peripheral Vascular Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 34: PTA Balloon Catheters Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 35: Renal Denervation Catheters Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 36: Superficial Vein Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 37: Vascular Embolization Plugs and Coils Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 38: Peripheral Vascular Devices Market, Mexico, Volume (Units), 2024-2036
Table 39: Arteriotomy Closure Devices Market, Mexico, Volume (Units), 2024-2036
Table 40: Carotid and Renal Artery Stents Market, Mexico, Volume (Units), 2024-2036
Table 41: Peripheral Accessories Market, Mexico, Volume (Units), 2024-2036
Table 42: Peripheral Embolic Protection Devices Market, Mexico, Volume (Units), 2024-2036
Table 43: Peripheral Vascular Stents Market, Mexico, Volume (Units), 2024-2036
Table 44: PTA Balloon Catheters Market, Mexico, Volume (Units), 2024-2036
Table 45: Renal Denervation Catheters Market, Mexico, Volume (Units), 2024-2036
Table 46: Superficial Vein Devices Market, Mexico, Volume (Units), 2024-2036
Table 47: Vascular Embolization Plugs and Coils Market, Mexico, Volume (Units), 2024-2036
Table 48: Peripheral Vascular Devices Market, Mexico, Average Price ($), 2024-2036
Table 49: Peripheral Vascular Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025
Table 50: Peripheral Vascular Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 51: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 52: Carotid and Renal Artery Stents Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 53: Peripheral Accessories Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 54: Peripheral Embolic Protection Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 55: Peripheral Vascular Stents Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 56: PTA Balloon Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 57: Renal Denervation Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 58: Superficial Vein Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 59: Vascular Embolization Plugs and Coils Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 60: Peripheral Vascular Devices Market, United States, Volume (Units), 2024-2036
Table 61: Arteriotomy Closure Devices Market, United States, Volume (Units), 2024-2036
Table 62: Carotid and Renal Artery Stents Market, United States, Volume (Units), 2024-2036
Table 63: Peripheral Accessories Market, United States, Volume (Units), 2024-2036
Table 64: Peripheral Embolic Protection Devices Market, United States, Volume (Units), 2024-2036
Table 65: Peripheral Vascular Stents Market, United States, Volume (Units), 2024-2036
Table 66: PTA Balloon Catheters Market, United States, Volume (Units), 2024-2036
Table 67: Renal Denervation Catheters Market, United States, Volume (Units), 2024-2036
Table 68: Superficial Vein Devices Market, United States, Volume (Units), 2024-2036
Table 69: Vascular Embolization Plugs and Coils Market, United States, Volume (Units), 2024-2036
Table 70: Peripheral Vascular Devices Market, United States, Average Price ($), 2024-2036
Table 71: Peripheral Vascular Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 72: Peripheral Vascular Devices Market Pipeline Products
Table 73: Peripheral Vascular Devices - Pipeline Products by Stage of Development
Table 74: Peripheral Vascular Devices Companies - Pipeline Products by Stage of Development
Table 75: Peripheral Vascular Devices - Pipeline Products by Segment
Table 76: Peripheral Vascular Devices - Pipeline Products by Territory
Table 77: Peripheral Vascular Devices - Pipeline Products by Regulatory Path
Table 78: Peripheral Vascular Devices - Pipeline Products by Estimated Approval Date
Table 79: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Peripheral Vascular Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Figure 2: Peripheral Vascular Devices Market, North America, Revenue ($m), USD Constant, 2024-2036
Figure 3: Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
Figure 4: Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
Figure 5: Peripheral Vascular Devices Market, North America, Company Share (%), 2025
Figure 6: Peripheral Vascular Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 7: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 8: Carotid and Renal Artery Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 9: Peripheral Accessories Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 10: Peripheral Embolic Protection Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 11: Peripheral Vascular Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 12: PTA Balloon Catheters Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 13: Renal Denervation Catheters Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 14: Superficial Vein Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 15: Vascular Embolization Plugs and Coils Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 16: Peripheral Vascular Devices Market, Canada, Volume (Units), 2024-2036
Figure 17: Arteriotomy Closure Devices Market, Canada, Volume (Units), 2024-2036
Figure 18: Carotid and Renal Artery Stents Market, Canada, Volume (Units), 2024-2036
Figure 19: Peripheral Accessories Market, Canada, Volume (Units), 2024-2036
Figure 20: Peripheral Embolic Protection Devices Market, Canada, Volume (Units), 2024-2036
Figure 21: Peripheral Vascular Stents Market, Canada, Volume (Units), 2024-2036
Figure 22: PTA Balloon Catheters Market, Canada, Volume (Units), 2024-2036
Figure 23: Renal Denervation Catheters Market, Canada, Volume (Units), 2024-2036
Figure 24: Superficial Vein Devices Market, Canada, Volume (Units), 2024-2036
Figure 25: Vascular Embolization Plugs and Coils Market, Canada, Volume (Units), 2024-2036
Figure 26: Peripheral Vascular Devices Market, Canada, Company Share (%), 2025
Figure 27: Peripheral Vascular Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 28: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 29: Peripheral Embolic Protection Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 30: Carotid and Renal Artery Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 31: Peripheral Accessories Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 32: Peripheral Vascular Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 33: PTA Balloon Catheters Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 34: Renal Denervation Catheters Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 35: Superficial Vein Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 36: Vascular Embolization Plugs and Coils Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 37: Peripheral Vascular Devices Market, Mexico, Volume (Units), 2024-2036
Figure 38: Arteriotomy Closure Devices Market, Mexico, Volume (Units), 2024-2036
Figure 39: Carotid and Renal Artery Stents Market, Mexico, Volume (Units), 2024-2036
Figure 40: Peripheral Accessories Market, Mexico, Volume (Units), 2024-2036
Figure 41: Peripheral Embolic Protection Devices Market, Mexico, Volume (Units), 2024-2036
Figure 42: Peripheral Vascular Stents Market, Mexico, Volume (Units), 2024-2036
Figure 43: PTA Balloon Catheters Market, Mexico, Volume (Units), 2024-2036
Figure 44: Renal Denervation Catheters Market, Mexico, Volume (Units), 2024-2036
Figure 45: Superficial Vein Devices Market, Mexico, Volume (Units), 2024-2036
Figure 46: Vascular Embolization Plugs and Coils Market, Mexico, Volume (Units), 2024-2036
Figure 47: Peripheral Vascular Devices Market, Mexico, Company Share (%), 2025
Figure 48: Peripheral Vascular Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 49: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 50: Carotid and Renal Artery Stents Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 51: Peripheral Accessories Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 52: Peripheral Embolic Protection Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 53: Peripheral Vascular Stents Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 54: PTA Balloon Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 55: Renal Denervation Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 56: Superficial Vein Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 57: Vascular Embolization Plugs and Coils Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 58: Peripheral Vascular Devices Market, United States, Volume (Units), 2024-2036
Figure 59: Arteriotomy Closure Devices Market, United States, Volume (Units), 2024-2036
Figure 60: Carotid and Renal Artery Stents Market, United States, Volume (Units), 2024-2036
Figure 61: Peripheral Accessories Market, United States, Volume (Units), 2024-2036
Figure 62: Peripheral Embolic Protection Devices Market, United States, Volume (Units), 2024-2036
Figure 63: Peripheral Vascular Stents Market, United States, Volume (Units), 2024-2036
Figure 64: PTA Balloon Catheters Market, United States, Volume (Units), 2024-2036
Figure 65: Renal Denervation Catheters Market, United States, Volume (Units), 2024-2036
Figure 66: Superficial Vein Devices Market, United States, Volume (Units), 2024-2036
Figure 67: Vascular Embolization Plugs and Coils Market, United States, Volume (Units), 2024-2036
Figure 68: Peripheral Vascular Devices Market, United States, Company Share (%), 2025
Figure 69: Peripheral Vascular Devices - Pipeline Products by Stage of Development
Figure 70: Peripheral Vascular Devices - Pipeline Products by Segment
Figure 71: Peripheral Vascular Devices - Pipeline Products by Territory
Figure 72: Peripheral Vascular Devices - Pipeline Products by Regulatory Path
Figure 73: Peripheral Vascular Devices - Pipeline Products by Estimated Approval Date
Figure 2: Peripheral Vascular Devices Market, North America, Revenue ($m), USD Constant, 2024-2036
Figure 3: Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
Figure 4: Peripheral Vascular Devices Market, North America, Volume (Units), 2024-2036
Figure 5: Peripheral Vascular Devices Market, North America, Company Share (%), 2025
Figure 6: Peripheral Vascular Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 7: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 8: Carotid and Renal Artery Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 9: Peripheral Accessories Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 10: Peripheral Embolic Protection Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 11: Peripheral Vascular Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 12: PTA Balloon Catheters Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 13: Renal Denervation Catheters Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 14: Superficial Vein Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 15: Vascular Embolization Plugs and Coils Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 16: Peripheral Vascular Devices Market, Canada, Volume (Units), 2024-2036
Figure 17: Arteriotomy Closure Devices Market, Canada, Volume (Units), 2024-2036
Figure 18: Carotid and Renal Artery Stents Market, Canada, Volume (Units), 2024-2036
Figure 19: Peripheral Accessories Market, Canada, Volume (Units), 2024-2036
Figure 20: Peripheral Embolic Protection Devices Market, Canada, Volume (Units), 2024-2036
Figure 21: Peripheral Vascular Stents Market, Canada, Volume (Units), 2024-2036
Figure 22: PTA Balloon Catheters Market, Canada, Volume (Units), 2024-2036
Figure 23: Renal Denervation Catheters Market, Canada, Volume (Units), 2024-2036
Figure 24: Superficial Vein Devices Market, Canada, Volume (Units), 2024-2036
Figure 25: Vascular Embolization Plugs and Coils Market, Canada, Volume (Units), 2024-2036
Figure 26: Peripheral Vascular Devices Market, Canada, Company Share (%), 2025
Figure 27: Peripheral Vascular Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 28: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 29: Peripheral Embolic Protection Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 30: Carotid and Renal Artery Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 31: Peripheral Accessories Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 32: Peripheral Vascular Stents Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 33: PTA Balloon Catheters Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 34: Renal Denervation Catheters Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 35: Superficial Vein Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 36: Vascular Embolization Plugs and Coils Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 37: Peripheral Vascular Devices Market, Mexico, Volume (Units), 2024-2036
Figure 38: Arteriotomy Closure Devices Market, Mexico, Volume (Units), 2024-2036
Figure 39: Carotid and Renal Artery Stents Market, Mexico, Volume (Units), 2024-2036
Figure 40: Peripheral Accessories Market, Mexico, Volume (Units), 2024-2036
Figure 41: Peripheral Embolic Protection Devices Market, Mexico, Volume (Units), 2024-2036
Figure 42: Peripheral Vascular Stents Market, Mexico, Volume (Units), 2024-2036
Figure 43: PTA Balloon Catheters Market, Mexico, Volume (Units), 2024-2036
Figure 44: Renal Denervation Catheters Market, Mexico, Volume (Units), 2024-2036
Figure 45: Superficial Vein Devices Market, Mexico, Volume (Units), 2024-2036
Figure 46: Vascular Embolization Plugs and Coils Market, Mexico, Volume (Units), 2024-2036
Figure 47: Peripheral Vascular Devices Market, Mexico, Company Share (%), 2025
Figure 48: Peripheral Vascular Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 49: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 50: Carotid and Renal Artery Stents Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 51: Peripheral Accessories Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 52: Peripheral Embolic Protection Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 53: Peripheral Vascular Stents Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 54: PTA Balloon Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 55: Renal Denervation Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 56: Superficial Vein Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 57: Vascular Embolization Plugs and Coils Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 58: Peripheral Vascular Devices Market, United States, Volume (Units), 2024-2036
Figure 59: Arteriotomy Closure Devices Market, United States, Volume (Units), 2024-2036
Figure 60: Carotid and Renal Artery Stents Market, United States, Volume (Units), 2024-2036
Figure 61: Peripheral Accessories Market, United States, Volume (Units), 2024-2036
Figure 62: Peripheral Embolic Protection Devices Market, United States, Volume (Units), 2024-2036
Figure 63: Peripheral Vascular Stents Market, United States, Volume (Units), 2024-2036
Figure 64: PTA Balloon Catheters Market, United States, Volume (Units), 2024-2036
Figure 65: Renal Denervation Catheters Market, United States, Volume (Units), 2024-2036
Figure 66: Superficial Vein Devices Market, United States, Volume (Units), 2024-2036
Figure 67: Vascular Embolization Plugs and Coils Market, United States, Volume (Units), 2024-2036
Figure 68: Peripheral Vascular Devices Market, United States, Company Share (%), 2025
Figure 69: Peripheral Vascular Devices - Pipeline Products by Stage of Development
Figure 70: Peripheral Vascular Devices - Pipeline Products by Segment
Figure 71: Peripheral Vascular Devices - Pipeline Products by Territory
Figure 72: Peripheral Vascular Devices - Pipeline Products by Regulatory Path
Figure 73: Peripheral Vascular Devices - Pipeline Products by Estimated Approval Date
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Melia Hotels International
- Intrepid Travel
- Design Hotels
- Vila Gale
- InterContinental Hotels Group (IHG)
- Marriott
